Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.37 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8805901 | 0.92 | ALDH1A1 (0.44) | LMNAALDH1A1HPGDHSD17B10ATM | |
| SCHEMBL28619888 | 0.88 | POLB (0.45) | LMNAPOLBHTTRXFP1ALDH1A1 | |
| SCHEMBL28628793 | 0.85 | TSHR (0.53) | LMNATSHR | |
| SCHEMBL2227651 | 0.85 | LMNA (0.39) | LMNAPOLBHTTRXFP1ALDH1A1 | |
| SCHEMBL29703417 | 0.85 | TSHR (0.53) | LMNATSHR | |
| SCHEMBL9843662 | 0.83 | MAPT (0.37) | LMNAPOLBHTTRXFP1ALDH1A1 | |
| SCHEMBL9843881 | 0.83 | MAPT (0.37) | LMNAPOLBHTTRXFP1ALDH1A1 | |
| SCHEMBL27477358 | 0.78 | MAPT (0.38) | LMNAPOLBHTTRXFP1ALDH1A1 | |
| SCHEMBL8805944 | 0.77 | ALDH1A1 (0.43) | LMNAPOLBHTTRXFP1ALDH1A1 | |
| SCHEMBL9253828 | 0.76 | MAPK1 (0.44) | LMNAALDH1A1HPGDHSD17B10ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102666496-A | New preparation method of 2- (2-N-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl) -N, N-dimethylacetamide | BORYUNG PHARM | 2012-09-12 | — | — | CN | claimed |
| WO-2011090323-A2 | NOVEL PREPARATION METHOD OF 2-(2-N-BUTYL-4-HYDROXY-6-METHYL-PYRIMIDIN-5-YL)-N,N-DIMETHYLACETAMIDE | BORYUNG PHARMACEUTICAL CO., LTD (KR) | 2011-07-28 | — | — | WO | claimed |
| CN-106674206-B | Co-crystal medicine for treating heart failure | 顾国明 | 2021-01-19 | — | — | CN | disclosed |
| CN-104478811-B | Fimasartan intermediate preparation method | 浙江浙邦制药有限公司 | 2017-01-25 | — | — | CN | disclosed |
| CN-102666496-B | Preparation method of 2- (2-N-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl) -N, N-dimethylacetamide | BORYUNG PHARM | 2015-05-20 | — | — | CN | disclosed |
| CN-104610164-A | New preparation of 2-(2-n-butyl-4-hydroxy-6-methyl-pyrimidine-5-yl)-n,n-dimethylacetamide | BORYUNG PHARM | 2015-05-13 | — | — | CN | disclosed |
| CN-104478811-A | Fimasartan intermediate preparation method | ZHEJIANG ZHEBANG PHARMACEUTICAL CO LTD | 2015-04-01 | — | — | CN | disclosed |
| CN-102666496-A | New preparation method of 2- (2-N-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl) -N, N-dimethylacetamide | BORYUNG PHARM | 2012-09-12 | — | — | CN | disclosed |
| CN-102666496-A | New preparation method of 2- (2-N-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl) -N, N-dimethylacetamide | BORYUNG PHARM | 2012-09-12 | — | — | CN | disclosed |
| WO-2011090323-A3 | NOVEL PREPARATION METHOD OF 2-(2-N-BUTYL-4-HYDROXY-6-METHYL-PYRIMIDIN-5-YL)-N,N-DIMETHYLACETAMIDE | BORYUNG PHARMACEUTICAL CO., LTD (KR) | 2011-11-10 | — | — | WO | disclosed |
| WO-2011090323-A2 | NOVEL PREPARATION METHOD OF 2-(2-N-BUTYL-4-HYDROXY-6-METHYL-PYRIMIDIN-5-YL)-N,N-DIMETHYLACETAMIDE | BORYUNG PHARMACEUTICAL CO., LTD (KR) | 2011-07-28 | — | — | WO | disclosed |
| WO-2011090323-A2 | NOVEL PREPARATION METHOD OF 2-(2-N-BUTYL-4-HYDROXY-6-METHYL-PYRIMIDIN-5-YL)-N,N-DIMETHYLACETAMIDE | BORYUNG PHARMACEUTICAL CO., LTD (KR) | 2011-07-28 | — | — | WO | disclosed |
| WO-2011090323-A2 | NOVEL PREPARATION METHOD OF 2-(2-N-BUTYL-4-HYDROXY-6-METHYL-PYRIMIDIN-5-YL)-N,N-DIMETHYLACETAMIDE | BORYUNG PHARMACEUTICAL CO., LTD (KR) | 2011-07-28 | — | — | WO | disclosed |